Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device

NOACs proved to be a feasible peri- and postprocedural alternative regimen to warfarin for preventing device-related thrombosis and thromboembolic complications expected early after appendage closure with the Watchman device, without increasing the risk of bleeding.